2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas
- Autores
- Campbell, Norm R.C.; Paccot Burnens, Melanie; Whelton, Paul K.; Angell, Sonia Y.; Jaffe, Marc G.; Cohn, Jennifer; Espinosa Brito, Alfredo; Irazola, Vilma; Brettler, Jeffrey W.; Roccella, Edward J.; Maldonado Figueredo, Javier Isaac; Rosende, Andres; Ordunez, Pedro
- Año de publicación
- 2022
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas.
Fil: Campbell, Norm R.C.. University of Calgary; Canadá. Pan American Health Organization; Estados Unidos
Fil: Paccot Burnens, Melanie. Ministerio de Salud de Chile; Chile
Fil: Whelton, Paul K.. University of Tulane; Estados Unidos
Fil: Angell, Sonia Y.. Columbia University; Estados Unidos
Fil: Jaffe, Marc G.. Kaiser Permanente San Francisco Medical Center; Estados Unidos
Fil: Cohn, Jennifer. University of Pennsylvania; Estados Unidos
Fil: Espinosa Brito, Alfredo. Hospital “Dr. Gustavo Aldereguía Lima”; Cuba
Fil: Irazola, Vilma. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina
Fil: Brettler, Jeffrey W.. Kaiser Permanente Bernard J. Tyson School of Medicine; Estados Unidos
Fil: Roccella, Edward J.. Lung and Blood Institute National Institutes of Health Bethesda; Estados Unidos
Fil: Maldonado Figueredo, Javier Isaac. Pan American Health Organization; Estados Unidos
Fil: Rosende, Andres. Pan American Health Organization; Estados Unidos
Fil: Ordunez, Pedro. Pan American Health Organization; Estados Unidos - Materia
-
CARDIOVASCULAR DISEASE
CLINICAL GUIDELINE
HEALTH POLICY
HEALTH SERVICES
HIGH BLOOD PRESSURE
HYPERTENSION
PUBLIC HEALTH - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
.jpg)
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/217138
Ver los metadatos del registro completo
| id |
CONICETDig_5777d7b1ac22f3e0dd47e3b063d35e9c |
|---|---|
| oai_identifier_str |
oai:ri.conicet.gov.ar:11336/217138 |
| network_acronym_str |
CONICETDig |
| repository_id_str |
3498 |
| network_name_str |
CONICET Digital (CONICET) |
| spelling |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the AmericasCampbell, Norm R.C.Paccot Burnens, MelanieWhelton, Paul K.Angell, Sonia Y.Jaffe, Marc G.Cohn, JenniferEspinosa Brito, AlfredoIrazola, VilmaBrettler, Jeffrey W.Roccella, Edward J.Maldonado Figueredo, Javier IsaacRosende, AndresOrdunez, PedroCARDIOVASCULAR DISEASECLINICAL GUIDELINEHEALTH POLICYHEALTH SERVICESHIGH BLOOD PRESSUREHYPERTENSIONPUBLIC HEALTHhttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas.Fil: Campbell, Norm R.C.. University of Calgary; Canadá. Pan American Health Organization; Estados UnidosFil: Paccot Burnens, Melanie. Ministerio de Salud de Chile; ChileFil: Whelton, Paul K.. University of Tulane; Estados UnidosFil: Angell, Sonia Y.. Columbia University; Estados UnidosFil: Jaffe, Marc G.. Kaiser Permanente San Francisco Medical Center; Estados UnidosFil: Cohn, Jennifer. University of Pennsylvania; Estados UnidosFil: Espinosa Brito, Alfredo. Hospital “Dr. Gustavo Aldereguía Lima”; CubaFil: Irazola, Vilma. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; ArgentinaFil: Brettler, Jeffrey W.. Kaiser Permanente Bernard J. Tyson School of Medicine; Estados UnidosFil: Roccella, Edward J.. Lung and Blood Institute National Institutes of Health Bethesda; Estados UnidosFil: Maldonado Figueredo, Javier Isaac. Pan American Health Organization; Estados UnidosFil: Rosende, Andres. Pan American Health Organization; Estados UnidosFil: Ordunez, Pedro. Pan American Health Organization; Estados UnidosElsevier2022-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/217138Campbell, Norm R.C.; Paccot Burnens, Melanie; Whelton, Paul K.; Angell, Sonia Y.; Jaffe, Marc G.; et al.; 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas; Elsevier; The Lancet Regional Health - Americas; 9; 5-2022; 1-102667-193XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2667193X22000369info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lana.2022.100219info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-10T13:17:49Zoai:ri.conicet.gov.ar:11336/217138instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-10 13:17:49.968CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
| dc.title.none.fl_str_mv |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| title |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| spellingShingle |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas Campbell, Norm R.C. CARDIOVASCULAR DISEASE CLINICAL GUIDELINE HEALTH POLICY HEALTH SERVICES HIGH BLOOD PRESSURE HYPERTENSION PUBLIC HEALTH |
| title_short |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| title_full |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| title_fullStr |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| title_full_unstemmed |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| title_sort |
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas |
| dc.creator.none.fl_str_mv |
Campbell, Norm R.C. Paccot Burnens, Melanie Whelton, Paul K. Angell, Sonia Y. Jaffe, Marc G. Cohn, Jennifer Espinosa Brito, Alfredo Irazola, Vilma Brettler, Jeffrey W. Roccella, Edward J. Maldonado Figueredo, Javier Isaac Rosende, Andres Ordunez, Pedro |
| author |
Campbell, Norm R.C. |
| author_facet |
Campbell, Norm R.C. Paccot Burnens, Melanie Whelton, Paul K. Angell, Sonia Y. Jaffe, Marc G. Cohn, Jennifer Espinosa Brito, Alfredo Irazola, Vilma Brettler, Jeffrey W. Roccella, Edward J. Maldonado Figueredo, Javier Isaac Rosende, Andres Ordunez, Pedro |
| author_role |
author |
| author2 |
Paccot Burnens, Melanie Whelton, Paul K. Angell, Sonia Y. Jaffe, Marc G. Cohn, Jennifer Espinosa Brito, Alfredo Irazola, Vilma Brettler, Jeffrey W. Roccella, Edward J. Maldonado Figueredo, Javier Isaac Rosende, Andres Ordunez, Pedro |
| author2_role |
author author author author author author author author author author author author |
| dc.subject.none.fl_str_mv |
CARDIOVASCULAR DISEASE CLINICAL GUIDELINE HEALTH POLICY HEALTH SERVICES HIGH BLOOD PRESSURE HYPERTENSION PUBLIC HEALTH |
| topic |
CARDIOVASCULAR DISEASE CLINICAL GUIDELINE HEALTH POLICY HEALTH SERVICES HIGH BLOOD PRESSURE HYPERTENSION PUBLIC HEALTH |
| purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.3 https://purl.org/becyt/ford/3 |
| dc.description.none.fl_txt_mv |
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas. Fil: Campbell, Norm R.C.. University of Calgary; Canadá. Pan American Health Organization; Estados Unidos Fil: Paccot Burnens, Melanie. Ministerio de Salud de Chile; Chile Fil: Whelton, Paul K.. University of Tulane; Estados Unidos Fil: Angell, Sonia Y.. Columbia University; Estados Unidos Fil: Jaffe, Marc G.. Kaiser Permanente San Francisco Medical Center; Estados Unidos Fil: Cohn, Jennifer. University of Pennsylvania; Estados Unidos Fil: Espinosa Brito, Alfredo. Hospital “Dr. Gustavo Aldereguía Lima”; Cuba Fil: Irazola, Vilma. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. Centro de Investigaciones en Epidemiología y Salud Pública. Instituto de Efectividad Clínica y Sanitaria. Centro de Investigaciones en Epidemiología y Salud Pública; Argentina Fil: Brettler, Jeffrey W.. Kaiser Permanente Bernard J. Tyson School of Medicine; Estados Unidos Fil: Roccella, Edward J.. Lung and Blood Institute National Institutes of Health Bethesda; Estados Unidos Fil: Maldonado Figueredo, Javier Isaac. Pan American Health Organization; Estados Unidos Fil: Rosende, Andres. Pan American Health Organization; Estados Unidos Fil: Ordunez, Pedro. Pan American Health Organization; Estados Unidos |
| description |
Cardiovascular disease (CVD) is the leading cause of death in the Americas and raised blood pressure accounts for over 50% of CVD. In the Americas over a quarter of adult women and four in ten adult men have hypertension and the diagnosis, treatment and control are suboptimal. In 2021, the World Health Organization (WHO) released an updated guideline for the pharmacological treatment of hypertension in adults. This policy paper highlights the facilitating role of the WHO Global HEARTS initiative and the HEARTS in the Americas initiative to catalyze the implementation of this guideline, provides specific policy advice for implementation, and emphasizes that an overarching strategic approach for hypertension control is needed. The authors urge health advocates and policymakers to prioritize the prevention and control of hypertension to improve the health and wellbeing of their populations and to reduce CVD health disparities within and between populations of the Americas. |
| publishDate |
2022 |
| dc.date.none.fl_str_mv |
2022-05 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
| format |
article |
| status_str |
publishedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/217138 Campbell, Norm R.C.; Paccot Burnens, Melanie; Whelton, Paul K.; Angell, Sonia Y.; Jaffe, Marc G.; et al.; 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas; Elsevier; The Lancet Regional Health - Americas; 9; 5-2022; 1-10 2667-193X CONICET Digital CONICET |
| url |
http://hdl.handle.net/11336/217138 |
| identifier_str_mv |
Campbell, Norm R.C.; Paccot Burnens, Melanie; Whelton, Paul K.; Angell, Sonia Y.; Jaffe, Marc G.; et al.; 2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas; Elsevier; The Lancet Regional Health - Americas; 9; 5-2022; 1-10 2667-193X CONICET Digital CONICET |
| dc.language.none.fl_str_mv |
eng |
| language |
eng |
| dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.sciencedirect.com/science/article/pii/S2667193X22000369 info:eu-repo/semantics/altIdentifier/doi/10.1016/j.lana.2022.100219 |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| eu_rights_str_mv |
openAccess |
| rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
| dc.format.none.fl_str_mv |
application/pdf application/pdf |
| dc.publisher.none.fl_str_mv |
Elsevier |
| publisher.none.fl_str_mv |
Elsevier |
| dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
| reponame_str |
CONICET Digital (CONICET) |
| collection |
CONICET Digital (CONICET) |
| instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
| repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
| _version_ |
1842980974404567040 |
| score |
12.993085 |